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Impacts of the COVID-19 Pandemic on Substance 
Use Treatment Capacity in Canada 
Key Findings 
• There was a substantial decrease in the availability and capacity of substance use treatment 
and harm reduction services in the early phase of the pandemic (March–June) due to closures 
and restrictions on the number of clients allowed at clinics and inpatient facilities.  
• This decrease, along with other factors, led to many clients returning to or engaging in higher-
risk substance use, and growing wait times for services. 
• Access to substance use treatment services and supports has not returned to pre-pandemic 
levels.  
• Delivery of care for substance use treatment shifted rapidly to virtual platforms, which had 
some positive impact on treatment access. 
• Availability of virtual care is not equitably distributed, and it cannot completely replace the 
need for in-person treatment options.  
Background 
The response to the COVID-19 pandemic has included 
many public health measures to contain the spread of the 
SARS-CoV-2 virus. These measures have substantially 
affected the provision of and access to services and 
supports for people who use substances. Some public 
health measures for COVID-19 have impacted patterns of 
substance use, the illicit drug supply, and the availability of 
and access to drugs in general (Canadian Centre on 
Substance Use and Addiction, 2020a; Nanos Research, 2020). Decreased access to substance use 
treatment, harm reduction services and other supports combined with the increased toxicity of the 
illicit drug supply has contributed to alarming increases in drug poisoning1 deaths since the 
pandemic began (British Columbia Coroners Service, 2020; Bridges, 2020; Government of Alberta, 
2020; Public Health Ontario, 2020).  
This document summarizes reported impacts of COVID-19 on substance use treatment capacity in 
Canada, including impacts on harm reduction services and related supports. In the absence of 
comprehensive data on treatment services in Canada, the summary brings together information from 
 
1 The term “drug poisoning” is used instead of “overdose” to reflect the toxicity of the drug supply and to avoid implications of personal 
responsibility.  
“I'm seeing a lot of people failing hard 
because distractions and routine in 
community are absent so everything falls 
apart … Lows feel lower and safety nets 
and supports are harder for some folks 
needing lower barrier support.” 
—psychiatric social worker 
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members of the National Treatment Indicators Working Group2 and anecdotal reports from 
treatment providers, supplemented by peer-reviewed and grey literature. The summary focuses on 
publicly funded and community-based treatment services and supports, and excludes inpatient and 
ambulatory services in psychiatric and general hospitals, crisis and emergency services, and primary 
care services. Privately funded treatment providers and services are also excluded.3 
This document includes quotes from treatment providers obtained through discussion boards at the 
online Recovery Capital Conference.4 Inclusion of the perspectives of frontline workers is critical, but 
the quotes do not necessarily represent the perspectives of all those working in treatment services.  
The summary is intended to inform policy makers about emerging findings on how the COVID-19 
pandemic and the public health response to it have impacted substance use treatment capacity and 
delivery in Canada. It is not a comprehensive overview and not all jurisdictions in Canada are 
represented, nor are all perspectives. It is meant to highlight some of the reported and perceived 
impacts of the pandemic on the delivery of treatment services and supports. The situation continues 
to evolve and additional evidence will likely emerge on the disruptions of the pandemic to services 
and supports for people who use substances.  
Reduced Access to Specialized Substance Use Treatment 
Services 
Specialized substance use treatment services include 
treatment facilities that typically offer withdrawal 
management and residential and outpatient treatment 
services such as counselling and group therapy. 
Jurisdictions in Canada reported a decline in the 
availability in these services during the first few months of 
the COVID-19 pandemic due to temporary closures or 
significant reductions in capacity to allow for physical distancing. For example: 
• Between the first week of March and the first week of April 2020, Ontario reported over a 
70% decrease in the total number of admissions (new registrations) to services across the 
province from 1,850 per week to 701 per week. As of the last week of August 2020, the total 
number of admissions remained 60% lower than numbers at the same time in 2019.5  
• Members of Addictions and Mental Health Ontario have observed significantly longer wait 
times for treatment because of reduced admittance capacity (0 to 80% of usual capacity), 
insufficient space to isolate clients before treatment and an increased average length of stay 
in residential treatment because of other delays or closures in the system (Addictions and 
Mental Health Ontario, 2020).   
 
2 The National Treatment Indicators Working Group includes representatives from the provinces and territories, and from national 
organizations involved with treatment delivery or reporting. The Working Group publishes biannual reports that have provided the only 
synthesis of national reporting on publicly funded, community-based treatment data across Canada. However, variability in scope and 
approach to data collection means that data obtained does not include all services and is not comparable across jurisdictions. 
3 Privately funded services are not covered by government health insurance plans and are paid for by the client. Privately funded 
treatment providers operate independently and are under no obligation to provide data to jurisdictional or federal authorities. 
4 The Recovery Capital Conference is an annual event to share the latest research on addiction treatment and recovery. In 2020, the 
conference was held virtually. The conference hosted virtual discussion boards to allow participants to network and connect. The quotes 
included in the summary are from these discussion boards. CCSA asked for and received consent to include each of these quotes.  
5 These numbers reflect publicly funded, community-based addiction treatment service providers that report to Ontario’s Drug and Alcohol 
Treatment Information System. 
“A lot of people relapsed, slipped and 
the lack of human connection took its 
toll for sure … Some places closed 
completely so longer wait times for 
everyone …” 
— rehabilitation counsellor 
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• In New Brunswick, the median number of days from intake assessment to receiving 
substance use services saw monthly increases from February to May from a median of 27 to 
68 days, and then decreases monthly from May to July from a median of 68 days to 28 days. 
The increase in wait times coincided with the “stay at home” public health campaign and 
addiction services adjusting to provide more virtual services across the province.   
Some jurisdictions have implemented interim support services to help provide clients with safe 
housing and related supports in the absence of residential treatment options. Regulatory changes to 
support physical distancing for medication-assisted therapies and other clinical approaches, 
including guidelines for prescribing substances, were implemented in many jurisdictions (Health 
Canada, 2020). Overall, these changes were not enough to compensate for disruptions in healthcare 
and support services for people who use substances, particularly early in the pandemic (Canadian 
Centre on Substance Use and Addiction, 2020b). For example, adherence to opioid agonist treatment 
in Alberta decreased from 86% in March to 53% in April and 56% in May (Government of Alberta, 
2020). Treatment adherence has since returned to 84%, 
likely reflecting increased availability of in-person services. 
Anecdotal reports from the Yukon indicated that clients 
receiving reduced intensity of care due to fewer available 
spaces in intensive service programs became more 
involved with other, related agencies such as the RCMP, 
emergency medical services and emergency shelters. 
Some of the safety precautions that have been added in 
response to the pandemic have also been challenging. 
Physical distancing and other public health measures have 
not only made it challenging for individuals to start their 
recovery in treatment, but have posed substantial 
challenges for their safety and mental wellbeing in the 
community (Canadian Centre on Substance Use and 
Addiction, 2020b).  
Increasing Use of Virtual Care 
Substance use services are increasingly using mobile or online platforms to mitigate the current 
difficulties in providing face-to-face care. Jurisdictions have actively worked to support the adoption 
of virtual care and supporting technology by all publicly funded service providers, including those 
providing opioid agonist treatment. Some providers have been able to pivot to virtual care models 
more readily than others. This variability is influenced by differences in regional limitations (rural vs. 
urban), treatment population groups, service categories (residential vs. community supports), and 
factors such as organization size and use of virtual services before the pandemic. For example: 
• In New Brunswick, the number of community-based substance use service deliveries, which 
represents any contact, support or treatment provided to an individual, increased on a 
monthly basis since the beginning of the pandemic from close to 1,300 service delivery 
events in February to a peak of over 2,500 in June. The format of service delivery episodes 
also changed significantly. In February, 67% of service delivery events were in person, with 
the rest occurring by phone or other formats. In April, 83% of service delivery events were 
provided by phone or through virtual care services. This increase likely represents the 
additional support during the pandemic provided to individuals currently receiving services, 
as well as a return to more expected levels. New Brunswick has not seen a significant 
increase in new requests for services.  
“Struggle is real for our members, they 
come in for treatment and if they show 
any signs or symptoms we need to 
isolate them in another building on site. 
We provide all meals and services until a 
negative covid test comes back and then 
they can return to the building. In early 
recovery it is very challenging as they 
often feel they are not “doing” recovery. 
Therefore they want to leave and we 
continue to maintain support and 
encouragement to keep them safe. I find 
they often struggle mostly to feeling like 
outcasts due to their addictions and now 
in recovery when we promote connection 
they feel like they are being outcasts 
again.” 
— addictions social worker 
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• From March 18 to June 1, outpatient clinical services in Prince Edward Island were delivered 
primarily by phone or web conference platform. There was a 9% increase in the number of 
patients accessing outpatient clinical services from March to August 2020, compared to the 
same period in 2019. There was also an 8% increase in admissions for withdrawal 
management from March to August 2020, compared to the same period in 2019.  
• Virtual care visits at the Centre for Addictions and Mental Health in Ontario increased from 
350 per month in March to 3,000 per month in April, an increase of more than 750% (Centre 
for Addiction and Mental Health, 2020a). These data speak to a pronounced and rapid shift 
to the provision of virtual care for substance use and substance use disorders.  
Virtual care is an important component of the spectrum of services for addiction treatment. It can 
remove barriers to treatment and more broadly improve access to healthcare services when existing 
services are disrupted. The increasing reliance on virtual care during the pandemic has created 
opportunities to improve care, while also posing challenges. While evidence on the use of virtual care 
for addiction treatment in response to the pandemic is emerging, the following anecdotes provide 
valuable insights into both its benefits and limitations:  
“With Covid 19 — Narcotics Anonymous meetings quickly started using virtual 
platforms. It’s awesome being able to connect to the Global NA fellowship and 
meetings in 144 different countries 24/7 to receive and provide support. This forum 
has also helped form new friendships with many other recovery members, which we 
otherwise wouldn’t have had the opportunity to meet. Addicts are actually getting 
clean and staying clean. We’ve become stronger and more united.” 
—public relations for Canadian Assembly of Narcotics Anonymous 
“We learned that [our] Intensive Outpatient Program could be delivered online which 
is great for people in remote communities and so on. We will be having an online 
section going forward.” 
—executive director of private treatment centre 
For others the challenges of virtual care were apparent: 
“Online meetings totally don’t work for my clients therefore the amount of relapsing 
seen among them is … being swiftly impacted.” 
—psychiatric social worker 
“Some people didn’t have access to technology for virtual group so they 
disconnected completely and when things started opening they had to go to detox all 
over again so detox had a huge waiting time … the [human] connection for mental 
health and addiction is more important than anything so we have to find a way to 
make room and make it safe so they can get support needed.” 
—rehabilitation counsellor 
Through discussions with partners and stakeholders and anecdotal accounts of the transition to 
virtual care because of COVID-19, several concerns arose. These concerns include the loss of clients 
when switching from in-person care to virtual platforms and the inability to deliver certain types of 
services online, such as safe consumption sites and other harm reduction services. Reports indicate 
that high-risk groups are left behind in the shift to virtual care, including rural and remote populations 
and marginalized populations who are socioeconomically vulnerable, street-entrenched or homeless. 
These people can be excluded from online services because they lack a fixed address or access to a 
phone, computer or internet connection. Logistical considerations around online care include the 
lack of safe spaces for some clients to take calls, as well as issues of trust with the security and 
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privacy of virtual sessions (Canadian Centre on Substance Use and Addiction, 2020b). Virtual care is 
clearly a crucial service, especially during a pandemic, but those delivering virtual care must be 
aware of its challenges and limitations. 
Impacts to Harm Reduction Services 
The early months of the pandemic saw closures and reduced capacity for several harm reduction 
services, including safe consumption sites, drop-in centres, shelters and outreach services. Many 
safe consumption sites are still operating under reduced hours, by appointment only or with limits on 
the number of clients allowed in the facility at one time. Some services reported difficultly 
communicating with clients about service closures, re-openings and operating hours (Canadian 
Centre on Substance Use and Addiction, 2020b). These changes have resulted in drastic reductions 
in the number of visits to safe consumption sites in Toronto, Alberta and British Columbia:  
• Monthly visits to The Works, a supervised injection service in Toronto, dropped from 3,853 in 
February 2020 to 127 in April 2020, and has only gone up to 790 visits in July 2020 
(Toronto Public Health, 2020).  
• From April to June 2020, there were 40,755 visits to supervised consumption services sites 
in Edmonton, Calgary, Lethbridge and Grande Prairie, and to the overdose prevention site in 
Red Deer. This is a decrease of 65% compared to 114, 430 visits in January to March 2020 
(Government of Alberta, 2020).  
• Monthly visits to overdose prevention sites and safe consumption sites in British Columbia 
declined from just under 60,000 in February 2020 to approximately 20,000 in April 2020, 
and has only increased to about 23,000 in July 2020 (BC Centre for Disease Control, 2020).  
Ongoing Challenges and 
Considerations  
The pandemic and the public health response to it have 
had an impact on many areas of healthcare service, 
including substance use treatment services and supports. 
Service providers themselves face increased challenges 
and stress while trying to provide care safely as they risk 
being exposed to the coronavirus. With an increased 
demand for virtual care, service providers will need training 
on the use of virtual platforms and technology-assisted 
services for client care (Centre for Addiction and Mental 
Health, 2020b). Developing and implementing virtual care 
models will need to consider not just the barriers to access 
and the range and availability of services, but also the 
training and supports required for delivering services (Rush 
& Furlong, 2020). 
Although the pandemic presents many challenges for treating those experiencing problematic 
substance use, it also allows for the development of novel models of care and for the overall delivery 
of care. There needs to be continued focus on improving the access to and availability of services 
and on addressing the unique needs of the different populations being served. It is critical that the 
effectiveness of virtual care and changes in the organization and delivery of care are evaluated to 
improve the capacity and delivery of services in a consistent and effective way (McMahon, Nadigel, 
“Not for profits need funds so they can 
supply or find places that are big enough 
to social distance. We had to rent the 
4th floor … costing us $1400. Now we 
are at a church but we also need extra 
funds so participants with compromised 
immune system or lack of income can be 
given help with transportation and help 
with the ability to have access to 
technology for virtual groups. Also, it’s 
extra stress on staff going to a bunch of 
different places doing in person and 
online and crisis travels that are all 
magnified by Covid so safety protection, 
counselling and resources, wage 
subsidies etc. would help staff to avoid 
burnout since we are working around the 
clock.” 
— rehabilitation counsellor 
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Thompson, & Glazier, 2020). Such evaluation requires rapidly available data on treatment services 
to measure demand and access, and to monitor whether the needs of different populations are 
being met. Research on the increased use and sustainability of virtual care is required to better 
understand the impact on access to services, delivery of care and outcomes (Rush & Furlong, 2020). 
To support these requirements, CCSA is collaborating with partners to understand the experience of 
Canadians engaged in virtual care for substance use and substance use disorders during the pandemic, 
as well as the experience of the healthcare professionals who provide them services and supports.  
While treatment services have not returned to pre-pandemic levels of availability, they have 
recovered some capacity. Wait times that lengthened in the early months of the pandemic remain. A 
surge is projected in demand for services because of ongoing stress and other negative psychosocial 
impacts of the pandemic. Treatment and harm reduction services will likely continue to maintain a 
range of structural and individual protective measures for service providers and clients. Increased 
awareness about the impacts of the pandemic on substance use treatment is needed to promote 
coordination and collaboration across the continuum of services and supports. CCSA is working to 
leverage its networks and communications platforms to mobilize evidence as it emerges and will 
continue to monitor how the pandemic is impacting substance use treatment.  
Recommended Resources 
• CCENDU Alert: Changes Related to COVID-19 in the Illegal Drug Supply and Access to 
Services, and Resulting Health Harms  
• Impacts of the COVID-19 Pandemic on People Who Use Substances: What We Heard  
• Rapid Access Models for Substance Use Services: A Rapid Review  
• Virtual Care for Mental Health and Substance Use During COVID-19 
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CCSA was created by Parliament to provide national leadership to address substance use in 
Canada. A trusted counsel, we provide national guidance to decision makers by harnessing 
the power of research, curating knowledge and bringing together diverse perspectives. 
CCSA activities and products are made possible through a financial contribution from 
Health Canada. The views of CCSA do not necessarily represent the views of Health 
Canada. 
